SC 13D
SC 13D
- Company
- aTYR PHARMA INC
- Filed
- May 15, 2015
- Accession Number
- 0001144204-15-031605
A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →